Business Context and Reporting Period
Company: Research Solutions, Inc. (RSSS)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three and six months ended December 31, 2024
Business Overview: A vertical SaaS and AI company providing research intelligence platforms (Discovery, Access, Manage) and transactional delivery of scientific, technical, and medical (STM) content. The company operates as a fully remote entity with subsidiaries in the U.S. and Mexico.
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 2024 | Six Months Ended Dec 31, 2024 |
|---|---|---|
| Total Revenue | $11,914,219 | $23,958,701 |
| Gross Profit | $5,821,093 (48.9% Margin) | $11,586,969 (48.4% Margin) |
| Operating Income (Loss) | $92,847 | $739,538 |
| Net Loss | $(1,980,234) | $(1,311,230) |
| Adjusted EBITDA | $962,956 | $2,235,491 |
| Cash and Equivalents | $7,701,155 (as of Dec 31, 2024) | |
| Contingent Earnout Liability | $14,705,000 (Total) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 15.5% ($1.6M) for the quarter and 17.6% ($3.6M) for the six-month period compared to the prior year.
- Platforms: Revenue surged 47.2% (quarter) and 56.0% (six months), driven by new deployments, customer expansion, and the Scite acquisition.
- Transactions: Revenue grew modestly by 1.7% (quarter) and 2.6% (six months) due to organic growth in copyright revenues.
- Profitability: Gross margin improved to 48.9% (quarter) and 48.4% (six months) from 43.5% and 41.8% respectively in the prior year, primarily due to lower personnel costs in the Platforms segment.
- Operating Expenses: Total operating expenses increased 16.8% (quarter) and 8.1% (six months).
- Sales & Marketing: Increased 66.9% (quarter) and 70.0% (six months) due to personnel costs and advertising related to the Scite acquisition.
- Depreciation & Amortization: Increased 96.6% (quarter) and 187.1% (six months) due to intangible assets from recent acquisitions.
- Net Loss Driver: The significant increase in net loss for the quarter (3,592% increase) and six months (25.9% increase) was primarily driven by a $2.4 million non-cash charge related to the change in fair value of the contingent earnout liability associated with the Scite acquisition.
Outlook, Risks, and Unusual Items
- Unusual Items: The financial results are heavily impacted by the revaluation of the contingent earnout liability for the Scite acquisition, which increased from $12.3 million (June 30, 2024) to $14.7 million (December 31, 2024). This resulted in a $2.4 million loss recognized in the period.
- Acquisitions: The company finalized valuations for the ResoluteAI and Scite acquisitions. Scite was acquired for approximately $21.1 million (cash, stock, and earnout), contributing significantly to revenue growth.
- Liquidity: The company generated $1.87 million in net cash from operating activities for the six months ended December 31, 2024. Cash balances increased to $7.7 million. A $500,000 revolving line of credit with PNC Bank is available but currently unutilized.
- Stock Repurchases: The Board authorized an increase in the repurchase cap to $1.5 million (price cap $5.50/share) to satisfy employee tax obligations on vesting. $891,615 remains available under this authorization.
- Risks: The filing notes no material changes to risk factors from the previous 10-K. Key risks include the uncertainty of the earnout liability valuation and reliance on third-party content publishers.
Investor Verification Checklist
- Earnout Liability Valuation: Verify the assumptions used in the Monte Carlo simulation for the Scite earnout liability, as a $2.4M adjustment significantly impacted net income.
- Platform Revenue Sustainability: Assess the retention rates and renewal terms for the new Scite and ResoluteAI customers driving the 56% platform revenue growth.
- Operating Leverage: Monitor if the 70% increase in Sales & Marketing expenses yields proportional long-term revenue growth or if margins compress.
- Cash Burn vs. Generation: Confirm the sustainability of positive operating cash flow given the high stock-based compensation and amortization expenses.
- Share Count: Note the increase in outstanding shares to 32.6 million due to option exercises and restricted stock grants, offset slightly by repurchases.